Compound that specifically binds to kir3dl2 for use in the treatment of peripheral t cell lymphoma
US-2025092130-A1 · Mar 20, 2025 · US
Buffet Renaud is listed as an inventor on 14 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Buffet Renaud |
| Total patents | 14 |
| First publication | Dec 31, 2015 |
| Latest publication | Mar 20, 2025 |
Publications ranked by popularity score, then publication date.
US-2025092130-A1 · Mar 20, 2025 · US
US-2024425586-A1 · Dec 26, 2024 · US
US-12084498-B2 · Sep 10, 2024 · US
US-11999784-B2 · Jun 4, 2024 · US
US-2021363248-A1 · Nov 25, 2021 · US
US-11078275-B2 · Aug 3, 2021 · US
US-2019315857-A1 · Oct 17, 2019 · US
US-10344087-B2 · Jul 9, 2019 · US
US-2019127463-A1 · May 2, 2019 · US
US-10174112-B2 · Jan 8, 2019 · US
Latest publications not already listed above.
US-2017298132-A1 · Oct 19, 2017 · US
US-2016136272-A1 · May 19, 2016 · US
US-2016002345-A1 · Jan 7, 2016 · US
US-2015376274-A1 · Dec 31, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Innate Pharma | 14 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G01N2333/70503 | 13 |
| C07K16/3061 | 13 |
| C07K2317/732 | 13 |
| C07K16/2803 | 13 |
| C07K2317/34 | 9 |